Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is following up on previous studies that have demonstrated that geriatric subjects respond different to ultraviolet B (UVB) light than young subjects. The treatment of geriatric skin with dermal rejuvenation therapies (dermabrasion, fractionated laser resurfacing) restores the appropriate UVB response. Ongoing studies have tested the ability of fractionated laser resurfacing (FLR) to assess how long this wounding effect lasts-and have found that this appears to be a durable response which lasts for at least two years. The findings that FLR protects geriatric skin at two years is the impetus for this study. This study is an interventional study to assess if FLR treatment of one forearm of geriatric subjects with multiple actinic keratosis will result in the short-term removal of actinic keratosis, and the long-term decrease in levels of future actinic keratosis and other non-melanoma skin cancers in comparison to the untreated arm. Study length and visit: The first part of the study is completed in 1 day then there are follow up visits at 90 days and every 6 months for 5 years.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 60 lat
- •Rozpoznane stwardniałe zmiany skórne w ciągu ostatnich 6 miesięcy
- •Jasna cera (typ Fitzpatrick I lub II)
- •Rozumienie procedury i związanych z nią ryzyk
- •Możliwość wyrażenia świadomej zgody
- •Posiadanie obu przedramion
✗ Disqualifies
- •Niekontrolowana cukrzyca
- •Alergia na lidokainę
- •Ciąża lub karmienie piersią
- •Historia gojenia się ze zwłóknieniami lub bliznami (w tym keloidami)
- •Choroby pogorszające się w słońcu
- •Przyjmowanie leków przeciwzapalnych (doustnych lub maści) lub sterydów
- •Duże tatuaże na przedramionach
- •Przyjmowanie leków zwiększających wrażliwość na słońce
Simplified criteria — AI translation
Trial details
- Minimum age
- 60 Years
- Last updated (source)
- July 17, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Dayton VA Medical Center
Dayton, United States
Trial contact
Manager, Clinical Research Operations
Regulatory Specialist
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.